0001596771-17-000041.txt : 20170531
0001596771-17-000041.hdr.sgml : 20170531
20170531162503
ACCESSION NUMBER: 0001596771-17-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170530
FILED AS OF DATE: 20170531
DATE AS OF CHANGE: 20170531
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemphire Therapeutics Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
BUSINESS PHONE: 248-980-6538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gullans Steven R. Ph.D.
CENTRAL INDEX KEY: 0001571997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 17881374
MAIL ADDRESS:
STREET 1: C/O EXCEL VENTURE MANAGEMENT, LLC
STREET 2: 800 BOYLSTON ST., STE 2825
CITY: BOSTON
STATE: MA
ZIP: 02199
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-05-30
0
0001638287
Gemphire Therapeutics Inc.
GEMP
0001571997
Gullans Steven R. Ph.D.
17199 N. LAUREL PARK DRIVE
SUITE 401
LIVONIA
MI
48152
1
1
0
0
Interim President & CEO
Employee Stock Option (right to buy)
10.26
2017-05-30
4
A
0
60000
0
A
2027-05-29
Common Stock
60000
60000
D
The option vests in 12 equal consecutive monthly increments, so that all of the shares will be vested on the one year anniversary of the date of grant, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer.
Stephanie Swan, by Power of Attorney
2017-05-31